ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) shares were up 0.8% on Friday . The company traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares were traded during trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Performance
The stock has a market cap of C$162.08 million and a P/E ratio of -7.30. The company has a fifty day moving average of C$6.50 and a 200 day moving average of C$6.50. The company has a debt-to-equity ratio of 1.70, a current ratio of 5.06 and a quick ratio of 4.29.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- What to Know About Investing in Penny Stocks
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- What is the Dow Jones Industrial Average (DJIA)?
- 10 Safe Investments with High Returns
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
